GURUFOCUS.COM » STOCK LIST » Real Estate » REITs » BioMed Realty Trust Inc (NYSE:BMR) » Definitions » Financial Strength

BioMed Realty Trust (BioMed Realty Trust) Financial Strength : 0 (As of Sep. 2015)


View and export this data going back to . Start your Free Trial

What is BioMed Realty Trust Financial Strength?

BioMed Realty Trust has the Financial Strength Rank of 0.

GuruFocus Financial Strength Rank measures how strong a company's financial situation is. It is based on these factors:

1. The debt burden that the company has as measured by its Interest Coverage (current year). The higher, the better.
2. Debt to revenue ratio. The lower, the better.
3. Altman Z-Score.

BioMed Realty Trust's Interest Coverage for the quarter that ended in Sep. 2015 was 2.01. BioMed Realty Trust's debt to revenue ratio for the quarter that ended in Sep. 2015 was 4.29. As of today, BioMed Realty Trust's Altman Z-Score is 0.00.


Competitive Comparison of BioMed Realty Trust's Financial Strength

For the REIT - Office subindustry, BioMed Realty Trust's Financial Strength, along with its competitors' market caps and Financial Strength data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BioMed Realty Trust's Financial Strength Distribution in the REITs Industry

For the REITs industry and Real Estate sector, BioMed Realty Trust's Financial Strength distribution charts can be found below:

* The bar in red indicates where BioMed Realty Trust's Financial Strength falls into.



BioMed Realty Trust Financial Strength Calculation

GuruFocus Financial Strength Rank measures how strong a company's financial situation is. It is based on these factors

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

1. The debt burden that the company has as measured by its Interest Coverage (current year). The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

BioMed Realty Trust's Interest Expense for the months ended in Sep. 2015 was $-16.7 Mil. Its Operating Income for the months ended in Sep. 2015 was $33.4 Mil. And its Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2015 was $2,532.2 Mil.

BioMed Realty Trust's Interest Coverage for the quarter that ended in Sep. 2015 is

Interest Coverage=-1*Operating Income (Q: Sep. 2015 )/Interest Expense (Q: Sep. 2015 )
=-1*33.44/-16.678
=2.01

The higher the ratio, the stronger the company's financial strength is.

2. Debt to revenue ratio. The lower, the better.

BioMed Realty Trust's Debt to Revenue Ratio for the quarter that ended in Sep. 2015 is

Debt to Revenue Ratio=Total Debt (Q: Sep. 2015 ) / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(463 + 2532.169) / 697.392
=4.29

3. Altman Z-Score.

Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.

The zones of discrimination were as such:

When Z-Score is less than 1.81, it is in Distress Zones.
When Z-Score is greater than 2.99, it is in Safe Zones.
When Z-Score is between 1.81 and 2.99, it is in Grey Zones.

BioMed Realty Trust has a Z-score of 0.00, indicating it is in Distress Zones. This implies bankrupcy possibility in the next two years.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BioMed Realty Trust  (NYSE:BMR) Financial Strength Explanation

The maximum rank is 10. Companies with rank 7 or higher will be unlikely to fall into distressed situations. Companies with rank of 3 or less are likely in financial distress.

BioMed Realty Trust has the Financial Strength Rank of 0.


BioMed Realty Trust Financial Strength Related Terms

Thank you for viewing the detailed overview of BioMed Realty Trust's Financial Strength provided by GuruFocus.com. Please click on the following links to see related term pages.


BioMed Realty Trust (BioMed Realty Trust) Business Description

Traded in Other Exchanges
N/A
Address
BioMed Realty Trust Inc, a Maryland corporation was formed on April 30, 2004 and commenced operations on August 11, 2004, after completing its initial public offering. The Company operates as a self-administered and self-managed real estate investment trust focused on acquiring, developing, owning, leasing and managing laboratory and office space for the life science industry mainly through its subsidiary, BioMed Realty, L.P., a Maryland limited partnership Its tenants mainly include biotechnology and pharmaceutical companies, scientific research institutions, government agencies and other entities involved in the life science industry. The Company's properties are generally located in markets with well established reputations as centers for scientific research, including Boston, San Diego, San Francisco, Seattle, Maryland, Pennsylvania and New York/ New Jersey. The Company faces competition from various entities for investment opportunities in properties for life science tenants, including other REITs, such as health care REITs and suburban office property REITs, pension funds, insurance companies, investment funds and companies, partnerships, and developers. The Company's properties are subject to various laws, ordinances and regulations, including regulations relating to common areas.
Executives
Daniel Bradbury director BIOBRIT, LLC, 2223 AVENIDA DE LA PLAYA, SUITE 108, LA JOLLA CA 92037
Brody William R Md Phd director MEDTRONIC, INC, 710 MEDTRONIC PKWY, MS LC310, MINNEAPOLIS MN 55432-5604
Janice L. Sears director 1100 PARK PLACE, SUITE 200, SAN MATEO CA 94403
Alan D Gold director, officer: Chairman, President and CEO 17140 BERNARDO CENTER DRIVE, SUITE 195, SAN DIEGO CA 92128
Gary A Kreitzer director, officer: Exec VP and Assistant Sec 17140 BERNARDO CENTER DRIVE, SUITE 195, SAN DIEGO CA 92128
Margaret Faye Wilson director 12836 LUNADA PLACE, SAN DIEGO CA 92128
Griffin R Kent Jr officer: President and COO 5950 SHERRY LANE, SUITE 700, DALLAS TX 75225
Richard I Gilchrist director 5950 SHERRY LANE, SUITE 700, DALLAS TX 75225